Cargando…
New drugs targeting Th2 lymphocytes in asthma
Asthma represents a profound worldwide public health problem. The most effective anti-asthmatic drugs currently available include inhaled β2-agonists and glucocorticoids and control asthma in about 90-95% of patients. The current asthma therapies are not cures and symptoms return soon after treatmen...
Autores principales: | Caramori, Gaetano, Groneberg, David, Ito, Kazuhiro, Casolari, Paolo, Adcock, Ian M, Papi, Alberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259400/ https://www.ncbi.nlm.nih.gov/pubmed/18315837 http://dx.doi.org/10.1186/1745-6673-3-S1-S6 |
Ejemplares similares
-
Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1
por: Mumby, Sharon, et al.
Publicado: (2023) -
RETRACTED ARTICLE: The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide
por: Perry, Mark M., et al.
Publicado: (2018) -
Retraction Note: The anti-proliferative and anti-inflammatory response of COPD airway smooth muscle cells to hydrogen sulfide
por: Perry, Mark M., et al.
Publicado: (2021) -
Pathophysiology of viral-induced exacerbations of COPD
por: Alfredo, Potena, et al.
Publicado: (2007) -
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease
por: Durham, Andrew L., et al.
Publicado: (2016)